New Approach to promote optic nerve regeneration and vision restoration
New Approach to promote optic nerve regeneration and vision restoration
批准号:
8105940
负责人:
ZHIGANG HE
金额:
$43.08万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2014-12-31
关键词:
AdultAffectAffinity ChromatographyAxonAxonal TransportAxotomyBehavioralCellsCircadian RhythmsCraniocerebral TraumaCytoskeletonDNA DamageDiseaseDown-RegulationEnzymesEventEyeEye diseasesFMR1 GeneFailureGlaucomaGlycogen Synthase Kinase 3HypoxiaInjuryKnock-outKnowledgeLightMediatingMessenger RNAMethodsMicroRNAsModelingMolecularMusMutant Strains MiceMutationNatural regenerationNerve FibersNeuronsOptic NerveOptic Nerve InjuriesOpticsPTEN genePathway interactionsPatientsPilot ProjectsPolyribosomesProtein BiosynthesisProteinsRecoveryRecovery of FunctionRetinalRetinal Ganglion CellsRibosomesRoleSet proteinSiteStressSynapsesTestingTherapeuticTimeTranslatingTranslationsTraumaTuberous SclerosisVisionaxon regenerationbiological adaptation to stresscombinatorialdesignfunctional restorationhuman DICER1 proteinhuman FRAP1 proteinin vivoinjuredinsightinterestmouse modelnovel strategiesnovel therapeuticsoptic nerve regenerationreconstitutionresponserestorationsuprachiasmatic nucleus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Optic nerve damage and regeneration failure are major features of trauma, glaucoma, and other blinding diseases. Developing strategies to promote anatomical regeneration and functional re-connection of injured optic nerve has been a long-standing challenge. We recently made a set of exciting discoveries showing that conditional deletion of PTEN (phosphatase and tensin homolog) or TSC1 (tuberous sclerosis 1) in adult retinal ganglion cells (RGCs) enabled robust long-distance axon regeneration after optic nerve injury (1), thereby establishing the first genetically defined mouse models with reproducible and robust optic nerve regeneration in the adult. The objectives of this proposed study are two-fold: to further explore the underlying mechanisms permitting axon regeneration in PTEN/TSC1 deleted neurons and to determine whether the regenerating axons could re-form synaptic connections and restore lost functions. We expect that the knowledge obtained from these studies can be translated into novel therapeutic strategies to promote functional recovery in patients with optic nerve injury, glaucoma and other types of eye diseases.
PUBLIC HEALTH RELEVANCE: Our recent findings that PTEN or TSC1 knockout promotes robust optic nerve regeneration provide an unprecedented opportunity to study the cellular and molecular mechanisms enabling adult RGC axons to regenerate. Furthermore, the availability of these genetically defined models allows us, for the first time, to explore post-regeneration events such as axon pathfinding, targeting, synaptic reconnection and behavioral recovery in vivo. These studies should provide much needed insights into developing therapeutic strategies to promote axon regeneration and vision restoration after head trauma, glaucoma and other eye-related diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10288673
-
项目类别:
-
资助金额:$13.22万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and spinal cord injury
-
批准号:9884826
-
项目类别:
-
资助金额:$43.06万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10599160
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10662464
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10018669
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10227071
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:9920148
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10915759
-
项目类别:
-
资助金额:$5.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Diversity Supplement)
-
批准号:10714331
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10094088
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10402334
-
项目类别:
-
资助金额:$51.77万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10712799
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and optimization of CBD-mediated analgesic effects (Admin Supplement)
-
批准号:10847933
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
CRSIPR screening for novel regulators of retinal ganglion cell survival and axonal regeneration
-
批准号:10610910
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
KCC2 and Spinal Cord Injury
-
批准号:10352309
-
项目类别:
-
资助金额:$42.02万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10475030
-
项目类别:
-
资助金额:$67.09万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:10468403
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Mechanism and Optimization of CBD-mediated analgesic effects
-
批准号:9895134
-
项目类别:
-
资助金额:$69.01万
-
财政年份:2019
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10349650
-
项目类别:
-
资助金额:$57.36万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
Cortical Signature and Modulation of Pain
-
批准号:10438580
-
项目类别:
-
资助金额:$79.54万
-
财政年份:2018
-
负责人:ZHIGANG HE
-
依托单位:
海外基金